Navigation Links
Pwnie Express Raises $5.1 Million Series A Funding
Date:7/30/2013

BERLIN, VT (PRWEB) July 30, 2013

Penetration testing innovator, Pwnie Express, closed on its $5.1 million Series A financing led by .406 Ventures and joined by Fairhaven Capital and the Vermont Seed Capital Fund. The new capital will broaden Pwnie's technology and product base, as well as expand sales and marketing capabilities.

Founded in 2009 by Dave Porcello, Pwnie Express has offices in Vermont and will soon open a Boston office. Winner of SC Magazine's Industry Innovator and Cyber Defense Magazine's Best in Class Pentest Award, Pwnie Express initially entered the market with its patent pending pentesting dropbox - the Pwn Plug. In 2012, Pwnie Express received DARPA funding to create the Power Pwn, a pentesting device in the form factor of a power strip. In Q1 2013, the company introduced the Pwn Pad, a pentester's tablet that has received critical acclaim and is in high demand. In May, Pwnie Express released Citadel PX, a scalable, enterprise class offering which provides the ability to easily and cost effectively conduct security assessments across multiple branch offices in a distributed enterprise.

Rick Grinnell, Managing Director of Fairhaven Capital said, “Pwnie Express is uniquely positioned with its innovative product suite to solve an enterprise security gap, creating a new high growth market segment.”

Maria Cirino, co-founder of .406 Ventures, said, "Pwnie Express has solved the problem of assessing the increased security risk from wireless and BYO devices, especially in remote and branch offices. Their specialized tools and highly differentiated approach to automating remote location penetration testing enables enterprise customers to do more testing for less money which maps well to today’s economic and IT security challenges." Cirino and Grinnell will both join the Pwnie Express Board of Directors.

About Pwnie Express:
Pwnie Express, established in 2009, is based in Berlin, Vermont with offices in Boston. Recognized by SC Magazine as the 2012 Industry Innovator, and serving over a thousand customers, Pwnie Express is the leading provider of penetration testing products for the distributed enterprise.

About .406 Ventures:
Established in 2006, .406 Ventures— whose name refers to the batting average of Boston Red Sox legend Ted Williams during the 1941 baseball season — focuses exclusively on early stage, enterprise IT companies, with a particular focus on highly differentiated companies in the IT security, health care IT and Web infrastructure spaces.

About Fairhaven Capital
Fairhaven Capital is a venture capital firm dedicated to a thesis-based approach to investing in North American technology companies. This approach focuses investment efforts on markets where emerging companies and technologies can create significant value.

About Vermont Seed Capital Fund:
Launched in 2010 with funding from the State of Vermont, the Vermont Seed Capital Fund is a $5M for-profit, permanently revolving, early-stage risk capital fund affiliated with the non-profit Vermont Center for Emerging Technologies (VCET).

Read the full story at http://www.prweb.com/releases/2013/7/prweb10964521.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Penetration Testing Product Company Pwnie Express is Headed for RSA 2013 with New Products and an Exciting Video Contest
2. Pwnie Express Next Stop: InfoSec World Orlando
3. Pwnie Express Releases Citadel PX for Distributed Penetration Testing
4. Pwnie Express Presents at Blackhat in Las Vegas
5. Changes in gene expression may help explain high blood pressure in pregnancy
6. Control of gene expression: Histone occupancy in your genome
7. Overexpression of proteins 14-3-3 related to chemotherapy resistance
8. Gene expression test identifies low-risk thyroid nodules
9. Internists express support for new payment and delivery models as basis for replacing SGR
10. Gene expression improves the definition of a breast cancer subtype
11. Wake-Up Call: Medical Malpractice Attorneys at Console & Hollawell Express Concern After Surgeon Gives Hepatitis B to Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International ... company, announced today that its iClinic V12.2 solution has achieved approval from National ... recently introduced PCMH 2017 standards which emphasize team-based care with a significant focus ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... May 23, 2017 , ... i2i Population Health, a national ... category winner, has named Daniel P. Bullington as chief technology officer. , “i2i ... and product offerings,” says Justin Neece, president. “Daniel is an excellent fit for ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment ... collagen and elastin in their face, neck, and body through a virtually pain-free, ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech ... in the modern ART laboratory, to provide hands-on training utilizing cutting-edge equipment at ... NextGen LifeLabs, a MedTech Group Purchasing vendor , will provide specialized equipment ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... May 4, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... the "Company"), today announced that the Company,s first quarter ... on Thursday, May 11, 2017, and that the Company ... 1:30 p.m. PT that afternoon. Management will provide an ...
(Date:5/3/2017)... 2017  Getinge, a leading global provider of ... and cost efficiency within healthcare and life sciences, ... practice demonstrating that intra-aortic balloon counterpulsation (IABC) appears ... patients. The single-center, retrospective, observational study showed that ... ® 50cc intra-aortic balloon (IAB) in contemporary ...
(Date:5/2/2017)... May 2, 2017  George Clinical, a leading full-service ... region, and Vector Oncology, a Memphis ... formally announced today that George Clinical has acquired ... has the dual purpose of strengthening the ability ... trial delivery solutions throughout the Asia-Pacific ...
Breaking Medicine Technology: